Role of phosphoproteomics in the development of personalized cancer therapies. (2015)
Attributed to:
In-depth quantification and characterisation of PI 3kinase signalling networks
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/prca.201400104
PubMed Identifier: 25488289
Publication URI: http://europepmc.org/abstract/MED/25488289
Type: Journal Article/Review
Volume: 9
Parent Publication: Proteomics. Clinical applications
Issue: 3-4
ISSN: 1862-8346